{"filing":{"accession_number":"0001104659-26-080741","cik":"0001175151","ticker":"CTSO","company_name":"Cytosorbents Corp","form":"8-K","filing_date":"2026-07-06","report_date":null,"primary_document":"tm2619724d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465926080741/tm2619724d1_8k.htm"},"events":[{"id":17029,"run_id":15248,"accession_number":"0001104659-26-080741","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"CytoSorbents received a written notice from Nasdaq on June 29, 2026, that it failed to comply with Nasdaq Listing Rule 5550(b)(2) due to its Market Value of Listed Securities falling below the $35 million minimum required for continued listing on the Nasdaq Capital Market. The company has been given a 180-day grace period (until December 28, 2026) to regain compliance, with explicit warning that failure to do so will result in delisting notification and potential loss of listing. This is a classic delisting-risk disclosure under Item 3.01.","company_name":"Cytosorbents Corp","ticker":"CTSO","filing_date":"2026-07-06","form":"8-K","submitted_at":null,"items":[{"id":15321,"accession_number":"0001104659-26-080741","item_number":"3.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"CytoSorbents received a written notice from Nasdaq on June 29, 2026, that it failed to comply with Nasdaq Listing Rule 5550(b)(2) due to its Market Value of Listed Securities falling below the $35 million minimum required for continued listing on the Nasdaq Capital Market. The company has been given a 180-day grace period (until December 28, 2026) to regain compliance, with explicit warning that failure to do so will result in delisting notification and potential loss of listing. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:45:54.721871+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15321,"accession_number":"0001104659-26-080741","item_number":"3.01","item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"CytoSorbents received a written notice from Nasdaq on June 29, 2026, that it failed to comply with Nasdaq Listing Rule 5550(b)(2) due to its Market Value of Listed Securities falling below the $35 million minimum required for continued listing on the Nasdaq Capital Market. The company has been given a 180-day grace period (until December 28, 2026) to regain compliance, with explicit warning that failure to do so will result in delisting notification and potential loss of listing. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-10T12:45:54.721871+00:00","company_name":"Cytosorbents Corp","ticker":"CTSO","filing_date":"2026-07-06"}]}